logo
Select company
Select metric
57.68%Cash to Assets Ratio
VS
Market
93
Sector
77
Industry
67
History
63
$ 11.1Close
$ 7.4 - $ 16.01 52-Week Range
Ticker Information

Ticker

KALV

Company Name

KALVISTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KALVISTA PHARMACEUTICALS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KALV - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 215.5M$ 124.3M57.68%
3/31/2025$ 250.77M$ 131.62M52.48%
12/31/2024$ 275.99M$ 167.29M60.61%
9/30/2024$ 160.83M$ 41.58M25.85%
6/30/2024$ 200.2M$ 31.85M15.91%
3/31/2024$ 235.4M$ 31.79M13.5%
12/31/2023$ 113.97M$ 23.06M20.23%
9/30/2023$ 138.74M$ 57.67M41.56%
6/30/2023$ 160.33M$ 49.41M30.82%
3/31/2023$ 183.2M$ 56.24M30.7%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KALVISTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash to Assets stands at 21.44%.
  • Over the past 5 years, KALVISTA PHARMACEUTICALS INC's average Cash to Assets has been 28.77%.
  • The median Cash to Assets for KALVISTA PHARMACEUTICALS INC during this period was 22.57%
  • KALVISTA PHARMACEUTICALS INC reached its highest Cash to Assets over the past 5 years at 60.61%.
  • The lowest Cash to Assets recorded by KALVISTA PHARMACEUTICALS INC in the same timeframe 13.5%

KALVISTA PHARMACEUTICALS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
INBX : INHIBRX BIOSCIENCES INC 87.95%PROK : PROKIDNEY CORP 22.83%NWBO : NORTHWEST BIOTHERAPEUTICS INC 14.61%ATAI : ATAI LIFE SCIENCES NV 32.74%SEPN : SEPTERNA INC 45.81%OTLK : OUTLOOK THERAPEUTICS INC 39.75%RNAC : CARTESIAN THERAPEUTICS INC 41.23%PLUR : PLURI INC 16.33%CLSD : CLEARSIDE BIOMEDICAL INC 61.15%IGC : IGC PHARMA INC 8.38%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for KALVISTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 16.17M ] / Assets [ $ 75.45M ]
(=) Cash to Assets [ 21.44% ]

KALV - Cash to Assets Ratio, Last 5 years

13.5%

Minimum

Mar 31, 2024

60.61%

Maximum

Dec 31, 2024

28.77%

Average

22.57%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%